Peter Kästner
Biomarker, Imaging, and Clinical Factors Associated With Overt and Covert Stroke in Patients With Atrial Fibrillation.
De Marchis G, Krisai P, Werlen L, Sinnecker T, Aeschbacher S, Dittrich T, Polymeris A, Coslovksy M, Blum M, Rodondi N, Reichlin T, Moschovitis G, Wuerfel J, Lyrer P, Fischer U, Conen D, Kästner P, Ziegler A, Osswald S, Kühne M, Bonati L, Swiss-AF investigators. Biomarker, Imaging, and Clinical Factors Associated With Overt and Covert Stroke in Patients With Atrial Fibrillation. Stroke 2023
Aug 7, 2023Biomarker, Imaging, and Clinical Factors Associated With Overt and Covert Stroke in Patients With Atrial Fibrillation.
Aug 7, 2023Stroke 2023
De Marchis Gian Marco, Krisai Philipp, Werlen Laura, Sinnecker Tim, Aeschbacher Stefanie, Dittrich Tolga, Polymeris Alexandros A, Coslovksy Michael, Blum Manuel R, Rodondi Nicolas, Reichlin Tobias, Moschovitis Giorgio, Wuerfel Jens, Lyrer Philippe A, Fischer Urs, Conen David, Kästner Peter, Ziegler Andreas, Osswald Stefan, Kühne Michael, Bonati Leo H, Swiss-AF investigators
Association of statin use and lipid levels with cerebral microbleeds and intracranial hemorrhage in patients with atrial fibrillation: A prospective cohort study.
Moutzouri E, Glutz M, Abolhassani N, Feller M, Adam L, Gencer B, Del Giovane C, Bétrisey S, Paladini R, Hennings E, Aeschbacher S, Beer J, Moschovitis G, Seiffge D, De Marchis G, Coslovsky M, Reichlin T, Conte G, Sinnecker T, Schwenkglenks M, Bonati L, Kästner P, Aujesky D, Kühne M, Osswald S, Fischer U, Conen D, Rodondi N. Association of statin use and lipid levels with cerebral microbleeds and intracranial hemorrhage in patients with atrial fibrillation: A prospective cohort study. Int J Stroke 2023:17474930231181010.
Jun 17, 2023Association of statin use and lipid levels with cerebral microbleeds and intracranial hemorrhage in patients with atrial fibrillation: A prospective cohort study.
Jun 17, 2023Int J Stroke 2023:17474930231181010
Moutzouri Elisavet, Glutz Matthias, Abolhassani Nazanin, Feller Martin, Adam Luise, Gencer Baris, Del Giovane Cinzia, Bétrisey Sylvain, Paladini Rebecca E, Hennings Elisa, Aeschbacher Stefanie, Beer Jürg Hans, Moschovitis Giorgio, Seiffge David J, De Marchis Gian Marco, Coslovsky Michael, Reichlin Tobias, Conte Giulio, Sinnecker Tim, Schwenkglenks Matthias, Bonati Leo H, Kästner Peter, Aujesky Drahomir, Kühne Michael, Osswald Stefan, Fischer Urs, Conen David, Rodondi Nicolas
Bone Morphogenetic Protein 10-A Novel Biomarker to Predict Adverse Outcomes in Patients With Atrial Fibrillation.
Hennings E, Blum S, Aeschbacher S, Coslovsky M, Knecht S, Eken C, Lischer M, Paladini R, Krisai P, Reichlin T, Rodondi N, Beer J, Ammann P, Conte G, De Perna M, Kobza R, Blum M, Bossard M, Kästner P, Ziegler A, Müller A, Bonati L, Pfister O, Zuern C, Conen D, Kühne M, Osswald S, Swiss‐AF Investigators. Bone Morphogenetic Protein 10-A Novel Biomarker to Predict Adverse Outcomes in Patients With Atrial Fibrillation. J Am Heart Assoc 2023; 12:e028255.
Mar 16, 2023Bone Morphogenetic Protein 10-A Novel Biomarker to Predict Adverse Outcomes in Patients With Atrial Fibrillation.
Mar 16, 2023J Am Heart Assoc 2023; 12:e028255
Hennings Elisa, Blum Steffen, Aeschbacher Stefanie, Coslovsky Michael, Knecht Sven, Eken Ceylan, Lischer Mirko, Paladini Rebecca E, Krisai Philipp, Reichlin Tobias, Rodondi Nicolas, Beer Jürg Hans, Ammann Peter, Conte Giulio, De Perna Maria Luisa, Kobza Richard, Blum Manuel R, Bossard Matthias, Kästner Peter, Ziegler Andreas, Müller Arndt-Christian, Bonati Leo H, Pfister Otmar, Zuern Christine S, Conen David, Kühne Michael, Osswald Stefan, Swiss‐AF Investigators
Insulin-like growth factor-binding protein 7 and risk of congestive heart failure hospitalization in patients with atrial fibrillation
Blum S, Conen D, Osswald S, Sticherling C, Baguley F, Kästner P, Blum M, Bonati L, Moschovitis G, Ammann P, Beer J, Rodondi N, Kühne M, Meyre P, Aeschbacher S, BEAT-AF and Swiss-AF Investigators. Insulin-like growth factor-binding protein 7 and risk of congestive heart failure hospitalization in patients with atrial fibrillation. Heart Rhythm 2020
Dec 3, 2020Insulin-like growth factor-binding protein 7 and risk of congestive heart failure hospitalization in patients with atrial fibrillation
Dec 3, 2020Heart Rhythm 2020
Blum Steffen, Conen David, Osswald Stefan, Sticherling Christian, Baguley Fiona, Kästner Peter, Blum Manuel R, Bonati Leo H, Moschovitis Giorgio, Ammann Peter, Beer Jürg H, Rodondi Nicolas, Kühne Michael, Meyre Pascal, Aeschbacher Stefanie, BEAT-AF and Swiss-AF Investigators
Early and late responses in patients with rheumatoid arthritis who were conventional synthetic disease-modifying anti-rheumatic drug inadequate responders and were treated with tocilizumab or switched to rituximab: an open-label phase 3 trial (MIRAI)
Dörner T, Peters M, Schwenke H, Rubbert-Roth A, Krüger K, Kurthen R, Kellner H, Kästner P, Engel A, Schmalzing M, Iking-Konert C, Burmester G, Schulze-Koops H, Tony H. Early and late responses in patients with rheumatoid arthritis who were conventional synthetic disease-modifying anti-rheumatic drug inadequate responders and were treated with tocilizumab or switched to rituximab: an open-label phase 3 trial (MIRAI). Clin Exp Rheumatol 2019; 37:937-945.
Apr 16, 2019Early and late responses in patients with rheumatoid arthritis who were conventional synthetic disease-modifying anti-rheumatic drug inadequate responders and were treated with tocilizumab or switched to rituximab: an open-label phase 3 trial (MIRAI)
Apr 16, 2019Clin Exp Rheumatol 2019; 37:937-945
Dörner Thomas, Peters Marvin A, Schwenke Holger, Rubbert-Roth Andrea, Krüger Klaus, Kurthen Reiner, Kellner Herbert, Kästner Peter, Engel Andreas, Schmalzing Marc, Iking-Konert Christof, Burmester Gerd-Rüdiger, Schulze-Koops Hendrik, Tony Hans-Peter